The investigators looked at 615 men treated to median dose of 73 Gy with median follow-up of 64 months and found PSA nadir ≥1.0 ng/mL to be highly predictive of distant failure as well as death from prostate cancer [13]. The gene discussed is KLK3; the disease is prostate cancer.